Govind Ragupathi

4.4k total citations
61 papers, 3.5k citations indexed

About

Govind Ragupathi is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Govind Ragupathi has authored 61 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 31 papers in Radiology, Nuclear Medicine and Imaging and 29 papers in Immunology. Recurrent topics in Govind Ragupathi's work include Glycosylation and Glycoproteins Research (43 papers), Monoclonal and Polyclonal Antibodies Research (27 papers) and Carbohydrate Chemistry and Synthesis (16 papers). Govind Ragupathi is often cited by papers focused on Glycosylation and Glycoproteins Research (43 papers), Monoclonal and Polyclonal Antibodies Research (27 papers) and Carbohydrate Chemistry and Synthesis (16 papers). Govind Ragupathi collaborates with scholars based in United States, Denmark and Australia. Govind Ragupathi's co-authors include Philip O. Livingston, David Y. Gin, Susan F. Slovin, Samuel J. Danishefsky, Stacy J. Keding, Jeffrey R. Gardner, Henrik Clausen, Chandra Hood, Sucharita Adluri and Nai‐Kong V. Cheung and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Govind Ragupathi

61 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Govind Ragupathi United States 38 2.4k 1.6k 905 884 612 61 3.5k
Tsui-Ling Hsu Taiwan 36 2.9k 1.2× 1.4k 0.9× 1.2k 1.3× 633 0.7× 509 0.8× 64 4.0k
F C Gaeta United States 26 1.9k 0.8× 1.8k 1.1× 636 0.7× 821 0.9× 352 0.6× 36 4.0k
Eduardo Osinaga Uruguay 29 1.5k 0.6× 945 0.6× 328 0.4× 435 0.5× 414 0.7× 83 2.3k
Fabio Dall’Olio Italy 35 2.7k 1.1× 1.5k 0.9× 607 0.7× 553 0.6× 367 0.6× 96 3.4k
Liliane Goetsch France 25 1.9k 0.8× 965 0.6× 323 0.4× 1.4k 1.6× 1.3k 2.1× 47 3.9k
Carolien A. M. Koeleman Netherlands 40 3.3k 1.4× 1.5k 0.9× 782 0.9× 1.7k 1.9× 124 0.2× 96 4.4k
Euphemia Leung New Zealand 35 2.2k 0.9× 1.2k 0.8× 473 0.5× 168 0.2× 815 1.3× 160 4.3k
Salomé S. Pinho Portugal 28 3.7k 1.5× 1.9k 1.2× 782 0.9× 471 0.5× 587 1.0× 60 4.5k
Catherine M. Radcliffe United Kingdom 24 2.2k 0.9× 964 0.6× 647 0.7× 784 0.9× 156 0.3× 31 3.2k
Yoann Rombouts France 28 1.7k 0.7× 1.1k 0.7× 261 0.3× 1.1k 1.3× 163 0.3× 55 2.8k

Countries citing papers authored by Govind Ragupathi

Since Specialization
Citations

This map shows the geographic impact of Govind Ragupathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Govind Ragupathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Govind Ragupathi more than expected).

Fields of papers citing papers by Govind Ragupathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Govind Ragupathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Govind Ragupathi. The network helps show where Govind Ragupathi may publish in the future.

Co-authorship network of co-authors of Govind Ragupathi

This figure shows the co-authorship network connecting the top 25 collaborators of Govind Ragupathi. A scholar is included among the top collaborators of Govind Ragupathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Govind Ragupathi. Govind Ragupathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kahn, Ryan, Govind Ragupathi, Qin Zhou, et al.. (2022). Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination. Cancer Immunology Immunotherapy. 72(1). 183–191. 5 indexed citations
2.
Fernández‐Tejada, Alberto, Constantine George, Nagavarakishore Pillarsetty, et al.. (2014). Development of a minimal saponin vaccine adjuvant based on QS-21. Nature Chemistry. 6(7). 635–643. 75 indexed citations
3.
Wu, Xiaohong, Govind Ragupathi, Katherine S. Panageas, Hong Feng, & Philip O. Livingston. (2013). Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation Is Associated with Activation of the PI3K/AKT Survival Pathway. Clinical Cancer Research. 19(17). 4728–4739. 11 indexed citations
4.
Viola, Nerissa T., Samuel L. Rice, Sean Carlin, et al.. (2013). Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology. Journal of Nuclear Medicine. 54(11). 1876–1882. 53 indexed citations
5.
Borgert, Andrew J., Jamie Heimburg‐Molinaro, Xuezheng Song, et al.. (2012). Deciphering Structural Elements of Mucin Glycoprotein Recognition. ACS Chemical Biology. 7(6). 1031–1039. 53 indexed citations
6.
Sawada, Ritsuko, Xiaohong Wu, Feng Hong, et al.. (2011). Human Monoclonal Antibodies to Sialyl-Lewisa (CA19.9) with Potent CDC, ADCC, and Antitumor Activity. Clinical Cancer Research. 17(5). 1024–1032. 71 indexed citations
7.
Lee, Hyunmi, Jimmy A. Rotolo, Judith Mesicek, et al.. (2011). Mitochondrial Ceramide-Rich Macrodomains Functionalize Bax upon Irradiation. PLoS ONE. 6(6). e19783–e19783. 129 indexed citations
8.
Ragupathi, Govind, Jeffrey R. Gardner, Philip O. Livingston, & David Y. Gin. (2011). Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer. Expert Review of Vaccines. 10(4). 463–470. 154 indexed citations
9.
Wandall, Hans H., Ola Blixt, Mads A. Tarp, et al.. (2010). Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes. Cancer Research. 70(4). 1306–1313. 201 indexed citations
10.
Ragupathi, Govind, Kai Deng, Michelle M. Adams, et al.. (2010). Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins. Vaccine. 28(26). 4260–4267. 31 indexed citations
11.
Ragupathi, Govind, K. Simon Yeung, Ping‐Chung Leung, et al.. (2008). Evaluation of widely consumed botanicals as immunological adjuvants. Vaccine. 26(37). 4860–4865. 56 indexed citations
12.
Slovin, Susan F., Govind Ragupathi, Andrew S. Wilton, et al.. (2007). A polyvalent vaccine for high-risk prostate patients: “are more antigens better?”. Cancer Immunology Immunotherapy. 56(12). 1921–1930. 63 indexed citations
13.
Livingston, Philip O., Chandra Hood, & Govind Ragupathi. (2006). Botanicals as immunological adjuvants and immunomodulators.. Cancer Research. 66. 1306–1307. 1 indexed citations
14.
Livingston, Philip O. & Govind Ragupathi. (2006). Cancer Vaccines Targeting Carbohydrate Antigens. Human Vaccines. 2(3). 137–143. 35 indexed citations
15.
Ragupathi, Govind, et al.. (2005). Antibodies against Tumor Cell Glycolipids and Proteins, but Not Mucins, Mediate Complement-Dependent Cytotoxicity. The Journal of Immunology. 174(9). 5706–5712. 57 indexed citations
16.
17.
Livingston, Philip O., Chandra Hood, Lee M. Krug, et al.. (2005). Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy. Cancer Immunology Immunotherapy. 54(10). 1018–1025. 43 indexed citations
18.
Ragupathi, Govind, Fusataka Koide, Maria Spassova, et al.. (2003). A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers. Cancer Immunology Immunotherapy. 52(10). 608–616. 46 indexed citations
19.
Ragupathi, Govind & Philip O. Livingston. (2002). The case for polyvalent cancer vaccines that induce antibodies. Expert Review of Vaccines. 1(2). 193–206. 11 indexed citations
20.
Adluri, Sucharita, et al.. (1999). Specificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21. British Journal of Cancer. 79(11-12). 1806–1812. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsui-Ling Hsu Breakdown of academic impact, for papers by F C Gaeta Breakdown of academic impact, for papers by Eduardo Osinaga Breakdown of academic impact, for papers by Fabio Dall’Olio Breakdown of academic impact, for papers by Liliane Goetsch Breakdown of academic impact, for papers by Carolien A. M. Koeleman Breakdown of academic impact, for papers by Euphemia Leung Breakdown of academic impact, for papers by Salomé S. Pinho Breakdown of academic impact, for papers by Catherine M. Radcliffe Breakdown of academic impact, for papers by Yoann Rombouts
Rankless by CCL
2026